Literature DB >> 1328299

Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.

L Legault1, P Cernacek, M Levy, E Maher, D Farber.   

Abstract

60% of chronic caval dogs with ascites did not respond to atrial natriuretic peptide (ANP) (75 ng.kg-1.min-1) with a natriuresis (TIVC-NR; delta UNaV = 2 +/- 0.8 mu eq/min) whereas the remaining 40% responded normally (TIVC-R; delta UNaV = 216 +/- 50 mu eq/min). Since proximal tubule neutral endopeptidase 24:11 (NEP) destroys most of intrarenal luminal ANP and kinins, we attempted to convert TIVC-NR into TIVC-R by providing NEP inhibition with SQ 28603 at 30 mg/kg. This potent and specific NEP inhibitor produced a natriuresis when administered alone to nine TIVC-NR dogs (delta UNaV = 67 +/- 2 mu eq/min) and permitted a natriuresis in the presence of ANP (delta UNaV = 97 +/- 18 mu eq/min). A natriuretic response to ANP could also be induced in TIVC-NR dogs by providing renal arterial bradykinin or intravenous captopril, a kininase inhibitor. Urodilatin, a natriuretic peptide not destroyed by intrarenal NEP was without effect in TIVC-NR dogs but increased UNaV when given to TIVC-R and normal dogs. Providing bradykinin to TIVC-NR now permitted an increment in delta UNaV (62 mu eq/min) when urodilatin was reinfused. TIVC-R dogs could be converted into TIVC-NR by pretreating with a specific bradykinin antagonist before infusing ANP. We conclude that TIVC-NR dogs are deficient in intrarenal kinins but are converted to responding dogs after NEP inhibition because of increased kinin delivery to the inner medullary collecting duct.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328299      PMCID: PMC443188          DOI: 10.1172/JCI116009

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis.

Authors:  F Salerno; S Badalamenti; P Incerti; L Capozza; L Mainardi
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

2.  Renal hemodynamics in response to a kinin analogue antagonist.

Authors:  W H Beierwaltes; O A Carretero; A G Scicli
Journal:  Am J Physiol       Date:  1988-09

3.  Heterogeneous renal responses to atrial natriuretic factor. II. Cirrhotic dogs.

Authors:  E Maher; P Cernacek; M Levy
Journal:  Am J Physiol       Date:  1989-11

4.  Cellular localisation of atrial natriuretic factor in the human kidney.

Authors:  C D Figueroa; H M Lewis; A G MacIver; J C Mackenzie; K D Bhoola
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

5.  Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.

Authors:  M R Wilkins; S L Settle; P T Stockmann; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Physiological features of edematous dogs unresponsive to atrial natriuretic peptide.

Authors:  E Maher; P Cernacek; M Levy
Journal:  Am J Physiol       Date:  1990-06

7.  In vivo microperfusion of inner medullary collecting duct in rats: effect of amiloride and ANF.

Authors:  H Sonnenberg; U Honrath; D R Wilson
Journal:  Am J Physiol       Date:  1990-08

8.  Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.

Authors:  G J Smits; D E McGraw; A J Trapani
Journal:  Am J Physiol       Date:  1990-05

9.  Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine.

Authors:  P Schulz-Knappe; K Forssmann; F Herbst; D Hock; R Pipkorn; W G Forssmann
Journal:  Klin Wochenschr       Date:  1988-09-01

Review 10.  Atrial natriuretic peptides in essential hypertension: basal plasma levels and relationship to sodium balance.

Authors:  G A Sagnella; N D Markandu; M G Buckley; M A Miller; D R Singer; F P Cappuccio; G A MacGregor
Journal:  Can J Physiol Pharmacol       Date:  1991-10       Impact factor: 2.273

View more
  1 in total

Review 1.  Neprilysin Inhibitors and Bradykinin.

Authors:  Duncan J Campbell
Journal:  Front Med (Lausanne)       Date:  2018-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.